Page 2 - Clinical Reader News Today

Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation

Human challenge models to advance vaccines against respiratory pathogens World Immunisation Week 2021 To mark World Immunisation Week 2021 from 24 to 30 April, the London School of Hygiene & Tropical Medicine (LSHTM) Vaccine Centre is hosting a series of webinars. The theme this year is ‘Vaccines Bring Us Closer’. Each day of the week we focus on an important area of vaccine research, science and debate bringing together experts in the field. We end the week with the�...

Press release content from Business Wire. The AP news staff was not involved in its creation. Ethics Approval Granted for Open Orphan’s COVID-19 Human Challenge Study Model February 17, 2021 GMT LONDON--(BUSINESS WIRE)--Feb 17, 2021-- Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces the world’s first COVID-19 characterizatio...

  Open Orphan plc (London and Euronext: ORPH) is a rapidly growing pharmaceutical service/contract research company that is a world leader in testing vaccines and antivirals using human challenge clinical trials. The company provides services to Big Pharma, biotech and government/public health organisations.   Open Orphan runs challenge studies in London from both its 19-bedroom Whitechapel quarantine clinic, opened in February 2021, and its 24-bedroom QMB clinic which also has a highly speci...

Researchers suggest ways to cope with long term Covid-19 symptoms February 11, 2021 × The study, published in the Oxford Open Immunology by Oxford University Press, stated that although Covid-19 was initially believed to be a short-term illness, a substantial number of patients experience symptoms beyond that A new study carried out by researchers at the King’s College London suggested some potential treatment strategies for patients suffering from Covid-19 long haul. The study, published in...

A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.

Stock photo of doctor and patient A NEW clinical trial could lead to less toxic treatment for blood cancer. Cardiff and Vale University Health Board is implementing a new clinical trial which will give blood cancer patients access to a promising, active lower intensity treatment option. The VICTOR clinical trial, which is funded by Cancer Research UK and led by Dr Richard Dillon from Guy’s Hospital in London, will examine the efficacy of venetoclax-based treatment in treating certain g...

 E-Mail Kings College London researchers have found evidence that minocycline, a widely used antibiotic with anti-inflammatory properties, gave greater improvement in depressive symptoms in patients with treatment resistant depression with low-grade peripheral inflammation. Improvement in depressive symptoms In a four-week randomised clinical MINDEP (MINocycline in DEPression) trial, 39 patients with major depressive disorder were recruited from services linked to South London and Maudsley N...

Antibiotic may improve depressive symptoms in people with low-level inflammation: Study ANI | Updated: Jan 28, 2021 11:29 IST Washington [US], January 28 (ANI): While antibiotics are widely used to treat bacterial infections and other illnesses, a new research suggested that minocycline, an antibiotic with anti-inflammatory properties, improved depressive symptoms in patients with low-grade peripheral inflammation. The findings of the study were published i...

Dr Ed Day Biography Dr Day is the UK government’s drug Recovery Champion. He is a clinician who has led the orientating of clinical practice towards recovery and has a research interest in recovery support services and mutual aid. He is a Clinical Reader in Addiction Psychiatry at the Institute for Mental Health at the University of Birmingham, and a Consultant Psychiatrist with Birmingham and Solihull Mental Health NHS Trust. He has been an expert advisor on addiction issues to Public He...